You are here: All Products  > Invivoscribe Submits Biomarker Test for Astellas Cancer Drug to China's NMPA

Invivoscribe Submits Biomarker Test for Astellas Cancer Drug to China's NMPA

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products